SCHEMBL16625840

SCHEMBL16625840

COc1cc2c(cc1O)C[C@H]1c3cc4c(cc3CCN1[C@H]2c1ccccc1)OCO4

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 7/20 0.61
DRD1 P21728 9/20 0.56
HTR1A P08908 3/20 0.56
CYP3A4 P08684 3/20 0.54
KDM4E B2RXH2 2/20 0.54
MAPT P10636 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
ALDH1A1 P00352 1/20 0.54
HPGD P15428 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
F3 P13726 5/20 0.52
CYP1A2 P05177 2/20 0.49
CYP2D6 P10635 2/20 0.49
DRD4 P21917 2/20 0.49
DRD5 P21918 2/20 0.49
CYP2C19 P33261 2/20 0.49
DRD3 P35462 2/20 0.49
ALOX15 P16050 1/20 0.49
HIF1A Q16665 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16625829 1.00 DRD2 (0.61) DRD2DRD1HTR1ACYP3A4KDM4E
SCHEMBL16627026 0.83 DRD1 (0.53) DRD2DRD1ALDH1A1DRD4DRD5
SCHEMBL16627024 0.83 DRD1 (0.53) DRD2DRD1ALDH1A1DRD4DRD5
SCHEMBL16625810 0.81 ALDH1A1 (0.47) DRD2DRD1MAPTALDH1A1HPGD
SCHEMBL16625801 0.81 ALDH1A1 (0.47) DRD2DRD1MAPTALDH1A1HPGD
SCHEMBL16625820 0.81 KDM4E (0.71) DRD2DRD1HTR1ACYP3A4KDM4E
SCHEMBL16625843 0.81 KDM4E (0.71) DRD2DRD1HTR1ACYP3A4KDM4E
SCHEMBL16627015 0.76 CA1 (0.54) DRD2DRD1DRD4DRD5DRD3
SCHEMBL16627013 0.76 CA1 (0.54) DRD2DRD1DRD4DRD5DRD3
SCHEMBL18626359 0.76 CA1 (0.52) DRD2DRD1KDM4EKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9181237-B2 Substituted berbines and their synthesis MALLINCKRODT LLC (US) 2015-11-10 US disclosed
US-9181237-B2 Substituted berbines and their synthesis MALLINCKRODT LLC (US) 2015-11-10 US disclosed
US-20150099772-A1 SUBSTITUTED BERBINES AND THEIR SYNTHESIS SUCAMPO PHARMA AMERICAS LLC 2015-04-09 US disclosed
US-20150099772-A1 SUBSTITUTED BERBINES AND THEIR SYNTHESIS SUCAMPO PHARMA AMERICAS LLC 2015-04-09 US disclosed
WO-2015051106-A1 SUBSTITUTED BERBINES AND THEIR SYNTHESIS MALLINCKRODT LLC (US) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099772-A1 SUBSTITUTED BERBINES AND THEIR SYNTHESIS TYMS, NME2, TYMP DRD2 2522/4885DRD1 2936/4885HTR1A 3596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.